Study summary · research use only
Serum levels of reduced glutathione, oxidized glutathione, and glutathione reductase activity in minor recurrent aphthous stomatitis patients
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This human case-control study enrolled 87 patients with idiopathic minor recurrent aphthous stomatitis (MiRAS) and 90 matched healthy individuals to evaluate serum reduced glutathione (GSH), oxidized glutathione (GSSG), and glutathione reductase (GR) activity. Serum GSSG, GR activity, and the GSSG/GSH ratio were higher in MiRAS patients, while serum GSH was lower. GSSG, GSH, and GSSG/GSH were each significantly associated with MiRAS, while GR was not. The authors describe serum GSSG as a potential risk factor and GSH and GSSG/GSH as potential protective factors in relation to MiRAS, without describing GR as playing an important role in its pathogenesis.
Abstract
Recurrent aphthous stomatitis (RAS) is one of the most prevalent oral mucosa diseases with unknown etiology. Reduced glutathione (GSH) is a major intracellular non-protein physiological antioxidant, and it has been demonstrated that GSH deficiency may be related to cardiovascular, immune, and diabetes. The purpose of this investigation was to evaluate the potential roles of GSH, oxidized glutathione (GSSG), and glutathione reductase (GR) in the etiopathogenesis of minor recurrent aphthous stomatitis (MiRAS). The study comprised 87 patients with idiopathic MiRAS and 90 race-, age-, and gender-matched healthy individuals. The spectrophotometric method was used to determine serum GSH and GSSG concentrations as well as GR activity. The GSSG/GSH ratios were subsequently computed. For statistical evaluation, the independent sample t test, Pearson's chi-square test, Mann-Whitney U test, Kruskal-Wallis H test, and Binary logistic regression analysis were used. The serum GSSG level, GR activity and GSSG/GSH ratio were statistically higher in MiRAS patients, whereas the concentration of serum GSH was significantly decreased. With the exception of GR, serum GSSG, GSH, and GSSG/GSH were all significantly associated with MiRAS. Serum GSSG can be regarded as a risk factor, whereas serum GSH and GSSG/GSH maybe considered as protective factors against the occurrence of MiRAS. GSSG may be a potential danger factor to MiRAS and GSH may be a protective factor, while GR may not play an important role in the aetiopathogenesis of MiRAS.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.